The independent source for health policy research, polling, and news.
341-360 of 4,031 results
A federal vaccine panel, recently reshaped by Health and Human Services Secretary Robert F. Kennedy Jr., is expected to vote on delaying the hepatitis B shot for newborns. Pediatricians warn that could open the door to a comeback for a disease virtually eradicated among U.S. children.
While patients wait to hear back from their doctors about test results, many turn to AI assistants for answers despite cautions over privacy and accuracy.
KFF Health News video producer Hannah Norman breaks down why new parents are getting billed thousands of dollars for births.
Michigan’s former top health official spent a year and $30 million building a system to implement work requirements for Medicaid recipients. The difficulties he encountered have him worried about 40 states and Washington, D.C., having to launch such systems by 2027.
Many people don’t know they can fight a health insurance denial, let alone how to do it. Here are practical tips for consumers who want to appeal a prior authorization decision.
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
The White House and congressional Republicans have made historic changes to the federal anti-hunger program SNAP. They say the changes will boost healthy eating for low-income Americans. Some nutrition experts aren’t so sure.
Four pediatricians said evidence-based science and medicine and a desire to keep kids healthy drive doctors’ childhood vaccination recommendations. And while pediatric practices might make money immunizing privately insured children, most practices likely break even or lose money from providing the shots.
The National Institutes of Health’s long-held standard of peer review for grantmaking has been subverted by President Donald Trump and NIH Director Jay Bhattacharya, who gave unprecedented power to politicos, NIH workers say.
Social Security, under the leadership of a tech enthusiast, rolled out an artificial intelligence-powered chatbot to answer calls. But as beneficiaries complain about glitches, lawmakers and former officials ask whether it’s a preview of a less human agency at which rushed-out AI takes the place of pushed-out government workers.
About 90,000 people spent months in limbo as central Missouri’s major, and often only, provider fought over insurance contracts. Patients getting caught in the crossfire of disputes has become a familiar complication, as about 8% of hospitals have left an insurer network since 2021. Trump administration policies could accelerate the trend.
The Trump administration's cuts of public health funds to state and local health departments had vastly uneven effects depending on the political leanings of where someone lives, a new KFF Health News analysis shows.
In a Goliath-versus-David fight, UnitedHealth Group’s pharmacy benefit manager, Optum Rx, has filed lawsuits in five counties to stop them from including the company in national opioid litigation.
Firearm violence is killing Americans at the scale of a public health epidemic. The suffering is concentrated in Black neighborhoods damaged by segregation, disinvestment, hate crimes, and other forms of racial discrimination.
Insurers will take drug costs, frequency of use, and other factors into account as they set premium amounts for the 2026 plan year.
In rural Colorado and across rural America, Medicaid is a lifeline, especially for people who wouldn’t otherwise have easy access to health care. That includes low-income seniors who need supplemental coverage in addition to Medicare, and people of all ages with disabilities.
Young adults without jobs that provide insurance find their options are limited and expensive. The problem is about to get worse.
It’s a difficult rite of passage for young adults without job-based insurance. Here are some tips for getting started.
Fired-then-reinstated workers at the Centers for Disease Control and Prevention worry about the future of public health amid proposed agency downsizing.
The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.
© 2026 KFF